 | • レポートコード：MRC2-11QY12254 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヒトマイクロバイオーム治療薬のグローバル市場について調査・分析したレポートです。種類別（FMT、マイクロバイオーム薬）市場規模、用途別（クロストリジウム・ディフィシル、クローン病、炎症性腸疾患、糖尿病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒトマイクロバイオーム治療薬の競争状況、市場シェア ・世界のヒトマイクロバイオーム治療薬市場：種類別市場規模 2015年-2020年（FMT、マイクロバイオーム薬） ・世界のヒトマイクロバイオーム治療薬市場：種類別市場規模予測 2021年-2026年（FMT、マイクロバイオーム薬） ・世界のヒトマイクロバイオーム治療薬市場：用途別市場規模 2015年-2020年（クロストリジウム・ディフィシル、クローン病、炎症性腸疾患、糖尿病、その他） ・世界のヒトマイクロバイオーム治療薬市場：用途別市場規模予測 2021年-2026年（クロストリジウム・ディフィシル、クローン病、炎症性腸疾患、糖尿病、その他） ・北米のヒトマイクロバイオーム治療薬市場分析：米国、カナダ ・ヨーロッパのヒトマイクロバイオーム治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒトマイクロバイオーム治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒトマイクロバイオーム治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒトマイクロバイオーム治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Enterome Bioscience、Rebiotix、Seres Therapeutics、Vedanta Biosciences、Bristol-Myers Squibb、Johnson & Johnson、Takeda Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Microbiome therapeutics are therapies that are designed to disrupt unhealthy microbial ecological networks and that catalyse the establishment of healthy ones.
One of the major drivers for this market is side effects of the existing treatments. Various medicines available in the market have several side-effects including minor headaches. These medicines may also impart serious side-effects such as liver or kidney injury, heart problems, and even death. The seriousness of side-effects drives the need for innovative treatment technologies, such as human microbiome therapeutics, that have reduced the negative impact on the human body. The demand for microbiome therapeutics is increasing since it provides treatment sans chemicals.
Market Analysis and Insights: Global Human Microbiome Therapeutics Market
The global Human Microbiome Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Human Microbiome Therapeutics Scope and Market Size
Human Microbiome Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Microbiome Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Enterome Bioscience
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson & Johnson
Takeda Pharmaceutical
…
Market segment by Type, the product can be split into
FMT
Microbiome Drugs
Market segment by Application, split into
C. difficile
Crohn’s Disease
Inflammatory Bowel Disease
Diabetes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Microbiome Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 FMT
1.4.3 Microbiome Drugs
1.5 Market by Application
1.5.1 Global Human Microbiome Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 C. difficile
1.5.3 Crohn’s Disease
1.5.4 Inflammatory Bowel Disease
1.5.5 Diabetes
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Therapeutics Market Perspective (2015-2026)
2.2 Global Human Microbiome Therapeutics Growth Trends by Regions
2.2.1 Human Microbiome Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Human Microbiome Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Human Microbiome Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Human Microbiome Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Human Microbiome Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Therapeutics Players by Market Size
3.1.1 Global Top Human Microbiome Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Human Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Human Microbiome Therapeutics Market Concentration Ratio
3.2.1 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Human Microbiome Therapeutics Revenue in 2019
3.3 Human Microbiome Therapeutics Key Players Head office and Area Served
3.4 Key Players Human Microbiome Therapeutics Product Solution and Service
3.5 Date of Enter into Human Microbiome Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Microbiome Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Human Microbiome Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Human Microbiome Therapeutics Market Size by Application (2015-2020)
5.2 Global Human Microbiome Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Human Microbiome Therapeutics Market Size (2015-2020)
6.2 Human Microbiome Therapeutics Key Players in North America (2019-2020)
6.3 North America Human Microbiome Therapeutics Market Size by Type (2015-2020)
6.4 North America Human Microbiome Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Human Microbiome Therapeutics Market Size (2015-2020)
7.2 Human Microbiome Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Human Microbiome Therapeutics Market Size by Type (2015-2020)
7.4 Europe Human Microbiome Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Human Microbiome Therapeutics Market Size (2015-2020)
8.2 Human Microbiome Therapeutics Key Players in China (2019-2020)
8.3 China Human Microbiome Therapeutics Market Size by Type (2015-2020)
8.4 China Human Microbiome Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Human Microbiome Therapeutics Market Size (2015-2020)
9.2 Human Microbiome Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Human Microbiome Therapeutics Market Size by Type (2015-2020)
9.4 Japan Human Microbiome Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Human Microbiome Therapeutics Market Size (2015-2020)
10.2 Human Microbiome Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Human Microbiome Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Human Microbiome Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Human Microbiome Therapeutics Market Size (2015-2020)
11.2 Human Microbiome Therapeutics Key Players in India (2019-2020)
11.3 India Human Microbiome Therapeutics Market Size by Type (2015-2020)
11.4 India Human Microbiome Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Human Microbiome Therapeutics Market Size (2015-2020)
12.2 Human Microbiome Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Human Microbiome Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Human Microbiome Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Enterome Bioscience
13.1.1 Enterome Bioscience Company Details
13.1.2 Enterome Bioscience Business Overview
13.1.3 Enterome Bioscience Human Microbiome Therapeutics Introduction
13.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2015-2020))
13.1.5 Enterome Bioscience Recent Development
13.2 Rebiotix
13.2.1 Rebiotix Company Details
13.2.2 Rebiotix Business Overview
13.2.3 Rebiotix Human Microbiome Therapeutics Introduction
13.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.2.5 Rebiotix Recent Development
13.3 Seres Therapeutics
13.3.1 Seres Therapeutics Company Details
13.3.2 Seres Therapeutics Business Overview
13.3.3 Seres Therapeutics Human Microbiome Therapeutics Introduction
13.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.3.5 Seres Therapeutics Recent Development
13.4 Vedanta Biosciences
13.4.1 Vedanta Biosciences Company Details
13.4.2 Vedanta Biosciences Business Overview
13.4.3 Vedanta Biosciences Human Microbiome Therapeutics Introduction
13.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.4.5 Vedanta Biosciences Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview
13.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Introduction
13.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview
13.6.3 Johnson & Johnson Human Microbiome Therapeutics Introduction
13.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Details
13.7.2 Takeda Pharmaceutical Business Overview
13.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Introduction
13.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.7.5 Takeda Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Human Microbiome Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Human Microbiome Therapeutics Revenue
Table 3. Ranking of Global Top Human Microbiome Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Human Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of FMT
Table 6. Key Players of Microbiome Drugs
Table 7. Global Human Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Human Microbiome Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Human Microbiome Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Human Microbiome Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Human Microbiome Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Human Microbiome Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Human Microbiome Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Human Microbiome Therapeutics Players
Table 18. Global Human Microbiome Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Human Microbiome Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Therapeutics as of 2019)
Table 21. Global Human Microbiome Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Human Microbiome Therapeutics Product Solution and Service
Table 24. Date of Enter into Human Microbiome Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Human Microbiome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Human Microbiome Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Human Microbiome Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Human Microbiome Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Human Microbiome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Human Microbiome Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Human Microbiome Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Human Microbiome Therapeutics Market Share (2019-2020)
Table 34. North America Human Microbiome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Human Microbiome Therapeutics Market Share by Type (2015-2020)
Table 36. North America Human Microbiome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Human Microbiome Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Human Microbiome Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Human Microbiome Therapeutics Market Share (2019-2020)
Table 40. Europe Human Microbiome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Human Microbiome Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Human Microbiome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Human Microbiome Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Human Microbiome Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Human Microbiome Therapeutics Market Share (2019-2020)
Table 46. China Human Microbiome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Human Microbiome Therapeutics Market Share by Type (2015-2020)
Table 48. China Human Microbiome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Human Microbiome Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Human Microbiome Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Human Microbiome Therapeutics Market Share (2019-2020)
Table 52. Japan Human Microbiome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Human Microbiome Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Human Microbiome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Human Microbiome Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Human Microbiome Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Human Microbiome Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Human Microbiome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Human Microbiome Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Human Microbiome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Human Microbiome Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Human Microbiome Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Human Microbiome Therapeutics Market Share (2019-2020)
Table 64. India Human Microbiome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Human Microbiome Therapeutics Market Share by Type (2015-2020)
Table 66. India Human Microbiome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Human Microbiome Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Human Microbiome Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Human Microbiome Therapeutics Market Share (2019-2020)
Table 70. Central & South America Human Microbiome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Human Microbiome Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Human Microbiome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Human Microbiome Therapeutics Market Share by Application (2015-2020)
Table 74. Enterome Bioscience Company Details
Table 75. Enterome Bioscience Business Overview
Table 76. Enterome Bioscience Product
Table 77. Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2015-2020) (Million US$)
Table 78. Enterome Bioscience Recent Development
Table 79. Rebiotix Company Details
Table 80. Rebiotix Business Overview
Table 81. Rebiotix Product
Table 82. Rebiotix Revenue in Human Microbiome Therapeutics Business (2015-2020) (Million US$)
Table 83. Rebiotix Recent Development
Table 84. Seres Therapeutics Company Details
Table 85. Seres Therapeutics Business Overview
Table 86. Seres Therapeutics Product
Table 87. Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2015-2020) (Million US$)
Table 88. Seres Therapeutics Recent Development
Table 89. Vedanta Biosciences Company Details
Table 90. Vedanta Biosciences Business Overview
Table 91. Vedanta Biosciences Product
Table 92. Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2015-2020) (Million US$)
Table 93. Vedanta Biosciences Recent Development
Table 94. Bristol-Myers Squibb Company Details
Table 95. Bristol-Myers Squibb Business Overview
Table 96. Bristol-Myers Squibb Product
Table 97. Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2015-2020) (Million US$)
Table 98. Bristol-Myers Squibb Recent Development
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Product
Table 102. Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2015-2020) (Million US$)
Table 103. Johnson & Johnson Recent Development
Table 104. Takeda Pharmaceutical Company Details
Table 105. Takeda Pharmaceutical Business Overview
Table 106. Takeda Pharmaceutical Product
Table 107. Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2015-2020) (Million US$)
Table 108. Takeda Pharmaceutical Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. FMT Features
Figure 3. Microbiome Drugs Features
Figure 4. Global Human Microbiome Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. C. difficile Case Studies
Figure 6. Crohn’s Disease Case Studies
Figure 7. Inflammatory Bowel Disease Case Studies
Figure 8. Diabetes Case Studies
Figure 9. Others Case Studies
Figure 10. Human Microbiome Therapeutics Report Years Considered
Figure 11. Global Human Microbiome Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Human Microbiome Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Human Microbiome Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Human Microbiome Therapeutics Market Share by Players in 2019
Figure 16. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Human Microbiome Therapeutics Revenue in 2019
Figure 18. North America Human Microbiome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Human Microbiome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Human Microbiome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Human Microbiome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Human Microbiome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Human Microbiome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Human Microbiome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
ヒトマイクロバイオームベース薬剤・診断の世界市場（～2026年） The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness. Rising cases of ch…- 炎症性腸疾患（IBD）の世界市場（～2026年） Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…
- ヒトパピローマウイルス（HPV）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Human Papillomaviru Therapeutics Market The global Human Papillomaviru Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Papillomaviru Therapeutics Scope and Market…
- ヒト血漿由来治療薬の世界市場（～2026年） Market Analysis and Insights: Global Human Plasma-Derived Therapeutics Market The global Human Plasma-Derived Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Plasma-Derived Therapeutics Scope and Mar…
- ヒト免疫不全ウイルス（HIV）-1治療薬の世界市場（～2026年） The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and can…